Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes

被引：0
|
作者：
Juurinen, L [1 ]
Tiikkainen, M [1 ]
Häkkinen, AM [1 ]
Järvinen, H [1 ]
机构：
[1] Univ Helsinki, FIN-00014 Helsinki, Finland
来源：
DIABETOLOGIA | 2005年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A59 / A59
页数：1
相关论文
共 50 条
  • [1] Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes
    Juurinen, Leena
    Tiikkainen, Mirja
    Hakkinen, Anna-Maija
    Hakkarainen, Antti
    Yki-Jarvinen, Hannele
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 292 (03): : E829 - E835
  • [2] Liver Fat Content and Hepatic Insulin Sensitivity in Overweight Patients With Type 1 Diabetes
    Llaurado, Gemma
    Sevastianova, Ksenia
    Sadevirta, Sanja
    Hakkarainen, Antti
    Lundbom, Nina
    Orho-Melander, Marju
    Groop, Per-Henrik
    Forsblom, Carol
    Yki-Jarvinen, Hannele
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (02): : 607 - 616
  • [3] Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes
    Cusi, K.
    Sanyal, A. J.
    Zhang, S.
    Hoogwerf, B. J.
    Chang, A. M.
    Jacober, S. J.
    Bue-Valleskey, J. M.
    Higdon, A. N.
    Bastyr, E. J., III
    Haupt, A.
    Hartman, M. L.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 : 50 - 58
  • [4] Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes
    Tiikkainen, M
    Häkkinen, AM
    Korsheninnikova, E
    Nyman, T
    Mäkimattila, S
    Yki-Järvinen, H
    [J]. DIABETES, 2004, 53 (08) : 2169 - 2176
  • [5] Effects of addition of rosiglitatzone to combination therapy with insulin and metformin on liver fat, insulin sensitivity, glycemic control and insulin requirements in patients with Type 2 diabetes requiring high doses of insulin
    Juurinen, L
    Tiikkainen, M
    Graner, M
    Häkkinen, AM
    Yki-Järvinen, H
    [J]. DIABETOLOGIA, 2004, 47 : A258 - A258
  • [6] Rosiglitazone reduces liver fat and insulin requirements and improves hepatic insulin sensitivity and glycemic control in patients with type 2 diabetes requiring high insulin doses
    Juurinen, Leena
    Kotronen, Anna
    Graner, Marit
    Yki-Jarvinen, Hannele
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (01): : 118 - 124
  • [7] The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes
    Mayerson, AB
    Hundal, RS
    Dufour, S
    Lebon, V
    Befroy, D
    Cline, GW
    Enocksson, S
    Inzucchi, SE
    Shulman, GI
    Petersen, KF
    [J]. DIABETES, 2002, 51 (03) : 797 - 802
  • [8] DIFFERENTIAL-EFFECTS OF INSULIN THERAPY ON HEPATIC AND PERIPHERAL INSULIN SENSITIVITY IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES
    NANKERVIS, A
    PROIETTO, J
    AITKEN, P
    HAREWOOD, M
    ALFORD, F
    [J]. DIABETOLOGIA, 1982, 23 (04) : 320 - 325
  • [9] Liver fat content, insulin absorption and action as determinants of insulin requirements in type 2 diabetes.
    Ryysy, L
    Häkkinen, AM
    Goto, T
    Vehkavaara, S
    Westerbacka, J
    Halavaara, J
    Yki-Järvinen, H
    [J]. DIABETOLOGIA, 1999, 42 : A83 - A83
  • [10] Liver fat content, insulin absorption and action sis determinants of insulin requirements in type 2 diabetes
    Ryysy, L
    Hakkinen, AM
    Halavaara, J
    Yki-Jarvinen, H
    [J]. DIABETES, 1999, 48 : A96 - A96
12345